Compare BioNano Genomics Inc (BNGO) vs Warner Music Group Corp (WMG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Warner Music Group Corp — how do they compare? BioNano Genomics Inc trades at $1.18 (market cap $13.20M), while Warner Music Group Corp trades at $28.38 (market cap $14.38B). The key difference: Warner Music Group Corp is far larger — about 1089.4× BioNano Genomics Inc's market cap, and Warner Music Group Corp pays a 2.76% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | WMG | |
|---|---|---|
Market Cap | $13.20M | $14.38B |
Sector | Health | Media |
52-Week High | $4.92 | $34.72 |
52-Week Low | $1.09 | $23.65 |
Enterprise Value | $15.81M | $18.58B |
Dividend Yield | — | 2.76% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bionano Genomics (BNGO) trades at $1.17, down 2.5% today, but maintains a bullish technical signal with strong moving average support. The company shows improving fundamentals with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable with a -109.95% net margin. Recent positive developments include debt retirement and growing adoption of optical genome mapping technology.
BNGO presents a high-risk, high-reward opportunity with analyst consensus leaning bullish (57% buy ratings). The stock trades at attractive valuation multiples (P/S 0.31, P/B 0.36) but faces execution risks in achieving profitability. Key catalysts include continued technology adoption and potential margin improvement, while persistent losses and competitive pressures remain concerns.
Warner Music Group (WMG) trades at $28.75, down 0.83% today, with a bullish technical signal and strong analyst consensus. Recent financials show revenue growth to $6.71B in 2025, though net income margin declined to 5.44%. The company maintains solid profitability with a 45.8% gross margin and recently acquired AI startup Sureel AI to enhance intellectual property management. Cash flow from operations remains healthy at $678M despite a net cash outflow of $159M in 2025.
WMG offers upside with a $40.40 consensus price target (40.5% potential) and 66.7% buy ratings, supported by streaming growth and AI initiatives. Risks include competitive pressures, margin volatility, and reliance on music industry trends. The stock's high P/E of 34.23 requires sustained earnings acceleration to justify valuation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Warner Music Group Corp
Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →
